SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950116-02-000184
Filing Date
2002-02-08
Accepted
2002-02-08 00:00:00
Documents
1
Period of Report
2002-03-18

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A def14a.txt DEF 14A 124628
  Complete submission text file 0000950116-02-000184.txt   126088
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 02530882
SIC: 2834 Pharmaceutical Preparations